$ABBV News Article - AbbVie Submits Supplemental N
Post# of 194
(Total Views: 456)
Posted On: 11/08/2019 12:40:42 PM
$ABBV News Article - AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA (ibrutinib) in Combination with Rituximab for the Treatment of Previously Untreated, Younger Adults with Chronic Lymphocytic Leukemia https://marketwirenews.com/news-releases/abbv...74247.html
(0)
(0)AbbVie Inc. (ABBV) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼